Climate Change Data

BioNTech SE

Climate Impact & Sustainability Data (2021, 2022)

Reporting Period: 2021

Environmental Metrics

Total Carbon Emissions:1,577,122 tCO2e
Scope 1 Emissions:886 tCO2e
Scope 2 Emissions:2,337 tCO2e
Scope 3 Emissions:1,573,898 tCO2e
Renewable Energy Share:39%
Total Energy Consumption:36,984 MWh
Water Consumption:72,000 m3
Waste Generated:896.7 tons

ESG Focus Areas

  • Access to Innovation
  • Democratize Access to Novel Medicine and Technological Innovation in Healthcare
  • Climate Protection
  • Attractive Employer
  • Responsible Governance

Environmental Achievements

  • 39% share of renewable energy in energy consumption in 2021
  • First full GHG footprint (Scope 1, 2 and 3) calculated

Social Achievements

  • Reduced employee turnover from 11.6% in 2020 to 6.6% in 2021
  • Launched a voluntary digital learning experience platform with access to LinkedIn Learning courses

Governance Achievements

  • Maintained a “Prime” ESG rating by rating agency ISS ESG
  • Strengthened compliance policies and target tracking

Climate Goals & Targets

Medium-term Goals:
  • Absolute reduction of 42% in Scope 1 and 2 GHG emissions by 2030
  • Supplier engagement target for Scope 3 GHG emissions by 2026
Short-term Goals:
  • Implement an ISO 50001-certified energy management and ISO 14001-certified environmental management system

Environmental Challenges

  • Growing ecological footprint with increased production
  • Challenges in vaccine equity
  • Managing the impact of the climate crisis on its business
Mitigation Strategies
  • Developed a climate protection strategy with SBTi-compliant targets
  • Scaled-up reliable production capacities
  • Developed BioNTainer – a sustainable, scalable solution for mRNA manufacturing
  • Addressing transition and physical climate risks

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct based on PSCI principles

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
Transition Risks
  • Regulatory changes

Reporting Standards

Frameworks Used: GRI Standards: Core option

UN Sustainable Development Goals

  • SDG 3: Good health and well-being

BioNTech's core business is aligned with SDG 3

Sustainable Products & Innovation

  • BioNTainer

Awards & Recognition

  • ISS ESG Prime rating
  • Princess of Asturias Award for Technical and Scientific Research
  • German Future Award

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:1,120,486 tCO2e/year
Scope 1 Emissions:801 tCO2e/year
Scope 2 Emissions:3,162 tCO2e/year
Scope 3 Emissions:1,116,523 tCO2e/year
Renewable Energy Share:41%
Total Energy Consumption:42,690 MWh/year
Water Consumption:75,000 m3/year
Waste Generated:1,488 tons/year
Carbon Intensity:374.12 tCO2e/€m (cost of sales)

ESG Focus Areas

  • Climate Protection
  • Responsible Governance
  • Attractive Employer
  • Democratize Access to Novel Medicine and Technological Innovation in Healthcare

Environmental Achievements

  • Increased share of renewable energy in energy consumption to 41% (from 39% in 2021)
  • 100% of business flight-related CO2e emissions mitigated through sustainable aviation fuels
  • Established Energy & Sustainability Projects (ESP) department to implement decarbonization targets.

Social Achievements

  • Launched BioNTainer, a flexible container solution for scalable, local vaccine production, with the first unit arriving in Rwanda in March 2023.
  • Expanded workforce by approximately 1,500 new jobs in 2022, with a total of 4,692 employees globally.
  • Increased corporate volunteering activities worldwide.
  • Appointed a Human Rights Officer.

Governance Achievements

  • Maintained ISS ESG prime rating and improved S&P ESG rating versus 2021.
  • Launched an interactive compliance e-learning program for employees.
  • Expanded executive compliance onboarding.
  • Established a compliance program in Rwanda.
  • 20% of variable Management Board remuneration linked to sustainability targets.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Achieve a 42% absolute reduction in Scope 1 and 2 GHG emissions by 2030 (compared to 2021 baseline).
  • Achieve near-term Scope 3 target by 2027 (supplier engagement).
Short-term Goals:
  • Complete implementation of ISO 14001, ISO 45001, and ISO 50001 standards by end of 2023.
  • Update CSR management program based on 2022/2023 materiality assessment (to be presented in 2023 report).

Environmental Challenges

  • Balancing company growth with climate targets.
  • Extending compliance culture to new global locations.
  • Managing the highest-ever number of external requests for support.
  • Integrating sustainability-related topics into the risk management system.
Mitigation Strategies
  • Established the Energy & Sustainability Projects (ESP) department.
  • Developed a revised Code of Business Conduct & Ethics.
  • Expanded CSR team and improved processes.
  • Implemented a plan to strengthen processes for collecting and processing sustainability-related data.

Supply Chain Management

Responsible Procurement
  • Supplier Code of Conduct (to be revised in 2023).

Climate-Related Risks & Opportunities

Physical Risks
  • Extreme weather events
  • Floods
  • Heatwaves
  • Rising sea levels
Transition Risks
  • Increasing carbon prices
  • Changes in regulations and markets
Opportunities
  • Decreasing raw material prices due to renewable energy transition
  • Increased demand for medicines due to climate change impacts

Reporting Standards

Frameworks Used: GRI Universal Standards 2021, SASB

Certifications: ISO 14001 (planned), ISO 45001 (planned), ISO 50001 (planned)

UN Sustainable Development Goals

  • SDG 3: Good health and well-being
  • SDG 5: Gender equality
  • SDG 7: Affordable and clean energy
  • SDG 13: Climate action

BioNTech's initiatives contribute to these goals through vaccine development and distribution, workforce diversity, renewable energy use, and climate protection efforts.

Sustainable Products & Innovation

  • BioNTainer